ValuEngine upgraded shares of Spectral Diagnostics Inc. (OTCMKTS:EDTXF) from a sell rating to a hold rating in a research report sent to investors on Monday morning.

Spectral Diagnostics (OTCMKTS EDTXF) opened at 0.31 on Monday. Spectral Diagnostics has a 12 month low of $0.14 and a 12 month high of $0.47. The company’s market cap is $64.31 million. The stock has a 50 day moving average price of $0.31 and a 200 day moving average price of $0.34.

ILLEGAL ACTIVITY WARNING: This piece of content was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of international copyright laws. The original version of this piece of content can be accessed at

About Spectral Diagnostics

Spectral Medical Inc, formerly Spectral Diagnostics Inc, is a therapeutic development company. The Company is focused on the development and commercialization of a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) and the Toraymyxin (PMX) therapeutic. The Company also manufactures and sells certain reagents.

Receive News & Ratings for Spectral Diagnostics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Diagnostics Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.